Proteome Sciences (PRM) Competitors GBX 3.70 -0.36 (-8.87%) As of 03/26/2025 12:45 PM Eastern Add Compare Share Share Competitors Stock AnalysisChartCompetitorsHeadlinesBuy This Stock PRM vs. VGAS, ALB, ADES, LOOP, PPG, REX, SMG, PCT, SLI, and LTHMShould you be buying Proteome Sciences stock or one of its competitors? The main competitors of Proteome Sciences include Volga Gas (VGAS), Albert Technologies (ALB), ADES International (ADES), LoopUp Group (LOOP), Plutus PowerGen (PPG), 3260041 (REX.L) (REX), 646143 (SMG.L) (SMG), Polar Capital Technology Trust (PCT), Standard Life Investments Property Income Trust (SLI), and James Latham (LTHM). These companies are all part of the "chemicals" industry. Proteome Sciences vs. Volga Gas Albert Technologies ADES International LoopUp Group Plutus PowerGen 3260041 (REX.L) 646143 (SMG.L) Polar Capital Technology Trust Standard Life Investments Property Income Trust James Latham Volga Gas (LON:VGAS) and Proteome Sciences (LON:PRM) are both small-cap basic materials companies, but which is the better stock? We will contrast the two businesses based on the strength of their community ranking, risk, analyst recommendations, earnings, valuation, institutional ownership, dividends, media sentiment and profitability. Do institutionals and insiders have more ownership in VGAS or PRM? 23.0% of Proteome Sciences shares are held by institutional investors. 19.5% of Proteome Sciences shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth. Which has preferable valuation and earnings, VGAS or PRM? Volga Gas has higher earnings, but lower revenue than Proteome Sciences. Proteome Sciences is trading at a lower price-to-earnings ratio than Volga Gas, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioVolga Gas£18.73M0.00N/A-£19.20N/AProteome Sciences£10.88B0.00-£4.08M-£1.38-2.68 Is VGAS or PRM more profitable? Volga Gas has a net margin of 0.00% compared to Proteome Sciences' net margin of -0.04%. Volga Gas' return on equity of 0.00% beat Proteome Sciences' return on equity.Company Net Margins Return on Equity Return on Assets Volga GasN/A N/A N/A Proteome Sciences -0.04%-0.01%-19.25% Does the MarketBeat Community believe in VGAS or PRM? Proteome Sciences received 72 more outperform votes than Volga Gas when rated by MarketBeat users. However, 73.77% of users gave Volga Gas an outperform vote while only 57.04% of users gave Proteome Sciences an outperform vote. CompanyUnderperformOutperformVolga GasOutperform Votes9073.77% Underperform Votes3226.23% Proteome SciencesOutperform Votes16257.04% Underperform Votes12242.96% Does the media refer more to VGAS or PRM? In the previous week, Volga Gas' average media sentiment score of 0.00 equaled Proteome Sciences'average media sentiment score. Company Overall Sentiment Volga Gas Neutral Proteome Sciences Neutral SummaryVolga Gas and Proteome Sciences tied by winning 5 of the 10 factors compared between the two stocks. Remove Ads Get Proteome Sciences News Delivered to You Automatically Sign up to receive the latest news and ratings for PRM and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart PRM vs. The Competition Export to ExcelMetricProteome SciencesDiagnostics & Research IndustryMedical SectorLON ExchangeMarket Cap£10.92M£704.46M£5.63B£2.62BDividend Yield6.17%5.44%4.55%4.95%P/E Ratio-2.681.7524.49142.45Price / Sales0.00338.22385.30278,804.97Price / Cash3.7311.4238.1627.95Price / Book-2.072.936.954.55Net Income-£4.08M£308.37B£3.20B£5.79B7 Day Performance-15.91%0.35%-2.19%0.47%1 Month Performance-24.26%-10.43%3.13%5.95%1 Year Performance2.78%-8.27%11.28%33.01% Proteome Sciences Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)PRMProteome SciencesN/AGBX 3.70-8.9%N/A+0.5%£10.92M£10.88B-2.68240Gap DownVGASVolga GasN/AN/AN/AN/A£18.99M£18.73M-1.222ALBAlbert TechnologiesN/AN/AN/AN/A£7.98M£4.61M-0.537,400Gap UpHigh Trading VolumeADESADES InternationalN/AN/AN/AN/A£5.09M£452.11M26.62140LOOPLoopUp GroupN/AN/AN/AN/A£1.43M£22.07M-5.8390PPGPlutus PowerGenN/AN/AN/AN/A£1.32M£1.17M-0.1952,000REX3260041 (REX.L)N/AN/AN/AN/A£0.00N/A0.00120SMG646143 (SMG.L)N/AN/AN/AN/A£0.00N/A0.006,100High Trading VolumePCTPolar Capital Technology TrustN/AGBX 305-0.7%N/A-89.6%£3.60B£1.24B2.99120Positive NewsHigh Trading VolumeSLIStandard Life Investments Property Income TrustN/AN/AN/AN/A£312.43M£29.95M3.672,021LTHMJames LathamN/AGBX 1,034-0.6%N/A-9.6%£204.26M£359.76M9.111,350Dividend Cut Remove Ads Related Companies and Tools Related Companies Volga Gas Competitors Albert Technologies Competitors ADES International Competitors LoopUp Group Competitors Plutus PowerGen Competitors 3260041 (REX.L) Competitors 646143 (SMG.L) Competitors Polar Capital Technology Trust Competitors Standard Life Investments Property Income Trust Competitors James Latham Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (LON:PRM) was last updated on 3/27/2025 by MarketBeat.com Staff From Our PartnersA market crash is coming—here’s whenThe stock market cycle I've used to identify the most likely day of the next market crash is the exact same in...Chaikin Analytics | SponsoredYour Wealth is Under AttackPlease don't wait—this is your moment to take action. Download your Wealth Protection Guide now, claim your fr...American Alternative | SponsoredA brutally honest economic warning for 2025 (see proof)New York Times best-selling financial author and world-renowned economist Addison Wiggin (a man who’s worked s...Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredHas Trump finally met his match?Dylan Jovine predicted the 2008 crash over a year before it happened. Folks who listened to him had the chance...Behind the Markets | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredEx CIA predicts 40% “double crash” – April 11The scientists here don’t study deadly viruses… directed energy weapons… or even weather control technology… ...Paradigm Press | Sponsored“Amazon Coin” set to outperform BitcoinChris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 diffe...True Market Insiders | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Proteome Sciences plc Please log in to your account or sign up in order to add this asset to your watchlist. Share Proteome Sciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.